TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive Thompson Names Texas Health Official Head Of HHS Center For Faith-Based Initiatives. March 23, 2001
TCL Archive NTP Bioassay Reports Will Include Other Tests In Assessing Potential Human Risk January 23, 1981
TCL Archive Karkin, Hatfield Vow to Amend Health Reform To Include Trust Fund For Medical Research June 4, 1993